Cargando…
Arterial wall fibrosis in Takayasu arteritis and its potential for therapeutic modulation
Arterial wall damage in Takayasu arteritis (TAK) can progress despite immunosuppressive therapy. Vascular fibrosis is more prominent in TAK than in giant cell arteritis (GCA). The inflamed arterial wall in TAK is infiltrated by M1 macrophages [which secrete interleukin-6 (IL-6)], which transition to...
Autores principales: | Misra, Durga Prasanna, Singh, Kritika, Sharma, Aman, Agarwal, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225504/ https://www.ncbi.nlm.nih.gov/pubmed/37256147 http://dx.doi.org/10.3389/fimmu.2023.1174249 |
Ejemplares similares
-
Outcome Measures and Biomarkers for Disease Assessment in Takayasu Arteritis
por: Misra, Durga Prasanna, et al.
Publicado: (2022) -
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis
por: Misra, Durga Prasanna, et al.
Publicado: (2021) -
Patient-Reported Outcome Measures in Takayasu Arteritis: A Systematic Review and Meta-Analysis
por: Misra, Durga P., et al.
Publicado: (2021) -
Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack—A Retrospective Cohort Study
por: Misra, Durga Prasanna, et al.
Publicado: (2022) -
Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India
por: Misra, Durga Prasanna, et al.
Publicado: (2022)